- abnormal immune system physiology / MGI
- decreased tumor growth/size / MGI
- impaired natural killer cell mediated cytotoxicity / MGI
- decreased cytotoxic T cell cytolysis / MGI
- immune system phenotype / MGI
- abnormal enzyme/coenzyme activity / MGI
- decreased T cell apoptosis / MGI
- increased sensitivity to induced morbidity/mortality / MGI
- abnormal NK cell physiology / MGI
C57BL/6NCrl-Gzmbem1(IMPC)Ccpcz/Ph
Status | Under development - register interest |
EMMA ID | EM:15452 |
International strain name | C57BL/6NCrl-Gzmbem1(IMPC)Ccpcz/Ph |
Alternative name | |
Strain type | Endonuclease-mediated |
Allele/Transgene symbol | Gzmbem1(IMPC)Ccpcz |
Gene/Transgene symbol | Gzmb |
Information from provider
Provider | Institute of Molecular Genetics |
Provider affiliation | Department of Transgenic Models of Diseases, Institute of Molecular Genetics |
Genetic information | This mouse line originates from CRISPR zygote microinjection. For further details see the project page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Institute of Molecular Genetics, Prague, Czech Republic |
Disease and phenotype information
MGI phenotypes (gene matching)
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).